Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:09 pm Sale | 13G | Allena Pharmaceuticals, Inc. ALNAQ | Third Rock Ventures II L.P. | 0 0.000% | -2,790,964 (Position Closed) | Filing History |
| 2023-02-14 4:06 pm Sale | 13G | Jounce Therapeutics, Inc. JNCE | Third Rock Ventures II L.P. | 335,533 0.600% | -3,794,934 (-91.88%) | Filing History |
| 2022-02-14 4:52 pm Sale | 13G | Jounce Therapeutics, Inc. JNCE | Third Rock Ventures II L.P. | 4,130,467 8.100% | -8,209,361 (-66.53%) | Filing History |
| 2021-02-16 4:06 pm Sale | 13G | Jounce Therapeutics, Inc. JNCE | Third Rock Ventures II L.P. | 12,339,828 31.000% | -939,292 (-7.07%) | Filing History |